cheap nike free runs china zorrilla

Singular negotiating team three or more, during the negotiations, to allow and encourage enterprises to explain to the public in an appropriate manner the price of drugs, efficacy, sales, etc., and for questioning the results of the negotiations will be released on public information platform, and to encourage drug manufacturer direct distribution within the procurement cycle once a year, on drug prices in principle remain unchanged. Negotiations 'noble drug' and the original patented drug research-based multinational pharmaceutical companies, will no doubt be the first to experience the system's. 'I can enter negotiation mechanism, depending on the patent medicine meets four basic principles, which is the first patented drugs, the presence of supply-side monopoly; second higher prices; third efficacy, clinical value; fourth , not yet. 'the vice-director of the Social security Department Dong Zhaohui said the Medicare chamber during an interview earlier this topic in the health insurance directory. In fact, civil products for multinational pharmaceutical companies to cut prices there have been voices - on the one hand, a significant effect of these drugs; but on the other hand, it is precisely because it put a lot of cost in the development stage, in order to encourage innovation and the development of these principles drugs also have the right to high pricing. 'If this program can be finalized is certainly a good thing, and we can use more of the public to better medicines, to the enterprise, but also to enter into a larger market.' Yesterday, the multinational pharmaceutical industry representatives , China Association of enterprises with foreign investment in pharmaceutical research and development industry committee (RDPAC) spokesman left by jade replied, 'first Financial Daily.' In 2010, the Department who will be part of the multinational pharmaceutical companies to introduce high-quality drugs Medicare attempts, Eli Lilly, Pfizer, Roche and harbinger of Nanjing, including a number of pharmaceutical companies, have different degrees of participation Medicare pilot negotiations. 'In fact, now the country are doing the work of negotiating drug prices, because the ability to pay for health insurance for each different area, so the principle of negotiation and variety is also somewhat different.' The aforementioned source says. Public information, since 2013, Jiangsu, Zhejiang and other economically developed provinces began to try provincial expensive drugs price negotiations. December 2014, Social Security will be 31 people in Zhejiang high value drugs included in the province's serious illness insurance special